African Union confronts funding crisis threatening disease control infrastructure across c

ACCRA, Ghana — African Union health officials convened an Extraordinary Summit this week confronting a governance crisis as consequential as any pathogen: the institutional and financial architecture sustaining the continent’s disease control systems is under severe strain, and no external actor can repair it from the outside.

The summit heard direct warnings that decades of progress against HIV, malaria and tuberculosis face reversal as international aid contracts and domestic health investment remains inadequate. Those warnings arrived against the backdrop of an active Ebola outbreak spreading through the Democratic Republic of the Congo, a crisis that has exposed the fragility of disease surveillance and response systems across the region.

Tedros Adhanom Ghebreyesus, head of the World Health Organization, placed the accountability question squarely before African governments. External partners can provide technical expertise, he told delegates, but the political commitment and financial resources must originate from within national institutions. “Strengthening health systems must be at the center of everything you decide in Accra,” Ghebreyesus said. “WHO stands with you as a partner, providing technical guidance and support. But only Africa’s leaders can deliver the political will and domestic investment this moment requires.”

That charge carries particular weight given the structural problem documented at the summit. Winnie Byanyima, executive director of UNAIDS, described how her organization’s Global Council on Inequality, AIDS and Pandemics has mapped a self-reinforcing cycle: inequalities create conditions for outbreaks to spread unchecked, while pandemics deepen inequalities within and between countries, leaving populations more exposed to future threats. “Breaking that cycle is one of the defining challenges of our time,” Byanyima told the meeting. The implication for policymakers is that health governance and economic governance cannot be treated as separate mandates.

The DRC outbreak sharpened the urgency. An Ebola case cluster identified in May has spread rapidly through the country’s eastern region, an area already destabilized by ongoing conflict. The strain involved is the Bundibugyo virus, for which neither a vaccine nor an approved treatment currently exists. Critically, the virus circulated undetected for weeks before identification, a surveillance failure that allowed transmission to accelerate before any coordinated response could be mounted.

By contrast, the summit’s agenda was designed precisely to address that kind of institutional gap. Officials organized two days of deliberations around three governance priorities: mobilizing political leadership to make health security a standing commitment rather than an emergency response, establishing cross-border coordination frameworks capable of managing outbreaks that do not respect national boundaries, and building local pharmaceutical manufacturing capacity so African institutions can produce vaccines and treatments rather than depend on external supply chains that have proved unreliable under pressure.

The manufacturing question is, in many respects, a sovereignty question. Dependence on imported health products leaves governments without meaningful control over their own pandemic response timelines. Developing domestic production capacity is a policy choice that requires sustained regulatory investment, industrial strategy, and procurement commitments from national health ministries, none of which can be delegated to international partners.

What the summit made plain is that the continent stands at a point where the decisions taken by heads of government and health ministers over the next few years will determine whether the gains of the past two decades hold. The institutional architecture for health security exists in outline. Whether African governments will fund it, staff it, and treat it as a core governance obligation, rather than a line item to be trimmed when aid flows fall, remains the open question that no summit resolution can answer on its own.